Saman Tajhiz Noor Competitors and Similar CompaniesClear all

Saman Tajhiz Noor's competitors and similar companies include Summit Diagnostics, SureScreen Diagnostics, Autobio Diagnostics and Zhejiang Orient Gene Biotech.

	Saman Tajhiz Noor Saman Tajhiz Noor is a company that develops laboratory equipment.	Summit Diagnostics Summit Diagnostics is a company that provides drug testing solutions.	SureScreen Diagnostics SureScreen Diagnostics is a company that provides rapid diagnostic equipment and services.	Autobio Diagnostics Autobio Diagnostics (奧託生物診斷有限公司) is a manufacturer and supplier of medical diagnostics products.	Zhejiang Orient Gene Biotech Zhejiang Orient Gene Biotech (浙江东方基因生物制品股份有限公司) is a company that manufactures and sells vitro diagnostic products,
Founding Date	Founding Date 1996	Founding Date 2007	Founding Date 1996	Founding Date 1998	Founding Date 2005
Type	Type Private	Type Private	Type Private	Type Public	Type Public
Tags	Tags Healthcare medical devices medical diagnostics	Tags Healthcare drug monitoring medical devices medical diagnostics	Tags Healthcare drug monitoring medical devices medical diagnostics	Tags Healthcare medical devices medical diagnostics	Tags Healthcare medical devices medical diagnostics
Locations	Locations Tehran, IR HQ	Locations Salem, US HQ	Locations Derby, GB HQ Cronulla, AU	Locations Zheng Zhou Shi, CN HQ	Locations Huzhou, CN HQ
Employees	Employees 32	Employees 18	Employees 53	Employees 5,773	Employees 2,231
Valuation ($)	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) 3.6 b	Valuation ($) 945.9 m
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) ¥4.1b (FY, 2025)	Revenue (est.) ¥910.7m (FY, 2025)
Cost of goods	Cost of goods N/A	Cost of goods N/A	Cost of goods N/A	Cost of goods ¥1.5b (FY, 2025)	Cost of goods ¥560.9m (FY, 2025)
Gross profit	Gross profit N/A	Gross profit N/A	Gross profit N/A	Gross profit ¥2.7b (FY, 2025)	Gross profit ¥366.6m (FY, 2025)
Net income	Net income N/A	Net income N/A	Net income N/A	Net income ¥1.1b (FY, 2025)	Net income (¥597.4m) (FY, 2025)